Equity · Healthcare
PRME
NASDAQPrime Medicine (PRME)
The line runs 3.26 USD on 11 August through 4.64 USD on 6 November, on a scale from 2 to 6. Days the market did not trade hold the previous close, flat.
- Market cap
- 841.6M USD
- Revenue, year to Dec 2025
- 4.6M USD
- EPS, diluted, year to Dec 2025
- −1.35 USD
- 52-week range
- 2.71 USD – 5.24 USD
- Avg volume
- 316.4K
- Mentions, 30 days
- 12
- Net sentiment
- +0.18
as of Nov 6, 2026
Which funds hold Prime Medicine (PRME)?
10 of the 45 institutional funds we track reported a Prime Medicine position for the quarter ended 30 Jun 2026 — a combined 66.3M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| ARK Investment Management | Added | 8,348,746 | 30.8M USD | +33.6% |
| Balyasny Asset Management | Held (±25%) | 3,969,082 | 14.6M USD | −3.7% |
| Citadel Advisors | Added | 2,054,543 | 7.6M USD | +510.8% |
| Two Sigma Investments | Held (±25%) | 1,524,511 | 5.6M USD | −3.1% |
| D. E. Shaw & Co. | Trimmed | 648,940 | 2.4M USD | −53.4% |
| Point72 Asset Management | New position | 533,553 | 2.0M USD | |
| Millennium Management | New position | 427,097 | 1.6M USD | |
| Marshall Wace | Added | 216,841 | 800K USD | +52.8% |
| AQR Capital Management | Trimmed | 117,998 | 435K USD | −78.7% |
| Renaissance Technologies | Trimmed | 117,412 | 433K USD | −84.2% |
What has been filed or recorded for Prime Medicine (PRME)?
The filings we hold for Prime Medicine, newest first: 8 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 142,780 shares | 474K USD notional · 0.079% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 55,829 shares | 202K USD notional · 0.031% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 15,107 shares | 54K USD notional · 0.008% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 30,831 shares | 120K USD notional · 0.017% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 22,122 shares | 77K USD notional · 0.012% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 12,996 shares | 39K USD notional · 0.007% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 282 shares | 871 USD notional · <0.001% of shares out |
| 25 Sep 2026 | Fails to deliver | Shares failed to deliver | 1,420 shares | 4K USD notional · 0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.24 USD | |
| 30 Jun 2026 | Financials | Total assets | 249.0M USD | at period end |
| 30 Jun 2026 | Financials | Total equity | 39.8M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.28 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −1.35 USD | Revenue $5M |
| 31 Dec 2025 | Financials | Revenue | 4.6M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −201.1M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −1.35 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.32 USD | Revenue $1M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.41 USD | Revenue $1M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.40 USD | Revenue $1M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −1.65 USD | Revenue $3M |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −0.44 USD | Revenue $0M |
What is Reddit saying about Prime Medicine (PRME)?
Reddit mentioned PRME 12 times in the 30 days to 9 November 2026, across 2 of the communities we track. All of them were scored for sentiment: 92% read bullish, 0% bearish and 8% neither. Reddit data updated 9 November 2026.
30-day window, Method
Mentions, 30 days 12Bullish 92%Bearish 0%Communities 2Against the market +38 points
How do Reddit mentions of Prime Medicine (PRME) compare with its price?
Share ↗
Where Prime Medicine (PRME) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 83% | 10 | +0.20 |
| r/stocks | 17% | 2 | +0.08 |
Prime Medicine (PRME): frequently asked questions
What did Prime Medicine shares close at?
Prime Medicine closed at 4.64 USD on 6 Nov 2026, up 4.27% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Prime Medicine’s market cap?
Prime Medicine is worth 841.6M USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Prime Medicine’s revenue?
Prime Medicine reported revenue of 4.6M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Which funds own Prime Medicine?
10 of the 45 funds we track reported a Prime Medicine position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were ARK Investment Management, Balyasny Asset Management and Citadel Advisors. See Funds
When did Prime Medicine last report earnings?
Prime Medicine last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.24 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Prime Medicine?
Prime Medicine was mentioned 0 times in the last 7 days across the finance subreddits we track, and 12 times over the trailing 30 days. Of the 12 mentions scored for sentiment, 92% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings